MOACM
ROIV icon

Mutual of America Capital Management’s Roivant Sciences ROIV Stock Holding History

Mutual of America Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.94M Sell
167,761
-5,032
-3% -$149K 0.06% 379
2026
Q1 		$4.79M Sell
172,793
-9,557
-5% -$246K 0.05% 416
2025
Q4 		$3.96M Sell
182,350
-16,335
-8% -$322K 0.04% 514
2025
Q3 		$3.01M Sell
198,685
-10,678
-5% -$132K 0.03% 638
2025
Q2 		$2.36M Sell
209,363
-7,317
-3% -$79.3K 0.03% 762
2025
Q1 		$2.19M Sell
216,680
-142,139
-40% -$1.54M 0.03% 797
2024
Q4 		$4.24M Sell
358,819
-9,047
-2% -$107K 0.05% 536
2024
Q3 		$4.25M Buy
367,866
+40,787
+12% +$464K 0.04% 552
2024
Q2 		$3.46M Buy
327,079
+1,142
+0.4% +$12.5K 0.04% 641
2024
Q1 		$3.44M Buy
325,937
+175,574
+117% +$1.89M 0.04% 663
2023
Q4 		$1.69M Buy
150,363
+28,504
+23% +$278K 0.02% 962
2023
Q3 		$1.42M Sell
121,859
-5,009
-4% -$56.6K 0.02% 980
2023
Q2 		$1.28M Buy
+126,868
New +$1.13M 0.01% 1018

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

Mutual of America Capital Management's ROIV Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Roivant Sciences (ROIV) stake by 2.9% in Q2 2026, selling an estimated $149K and leaving 167,761 shares worth $5.94M. The position accounts for 0.06% of the portfolio, ranked #379.

Mutual of America Capital Management first reported a position in ROIV in Q2 2023 and has held it in 13 quarters since. 351 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Mutual of America Capital Management held 167,761 shares of Roivant Sciences worth $5.94M as of Q2 2026.
  • Mutual of America Capital Management sold 5,032 Roivant Sciences shares in Q2 2026, an estimated $149K.
  • Roivant Sciences made up 0.06% of Mutual of America Capital Management's portfolio in Q2 2026, its #379 holding.
  • Mutual of America Capital Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 13 quarters since.
  • 351 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.